Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Oct 15, 2023; 15(10): 1829-1834
Published online Oct 15, 2023. doi: 10.4251/wjgo.v15.i10.1829
Published online Oct 15, 2023. doi: 10.4251/wjgo.v15.i10.1829
Date | Event |
November 2020 | Diagnosed with metastatic colon adenocarcinoma and started on panitumumab, 5-fluorouracil and leucovorin |
January 2021 | Switched to trifluridine/tipiracil |
November 2021 | Disease progression on CT imaging |
December 2021 | Switched to regorafenib |
February 2022 | Switched to osimertinib |
November 2023 | Died |
- Citation: Buzard B, Douglass L, Gustafson B, Buckley J, Roth M, Kujtan L, Bansal D. Response to osimertinib in a colorectal cancer patient with an EGFR T790M mutation: A case report. World J Gastrointest Oncol 2023; 15(10): 1829-1834
- URL: https://www.wjgnet.com/1948-5204/full/v15/i10/1829.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i10.1829